Surgical Equipment Q1 Earnings: CONMED (CNMD) Tops Estimates, Zimmer Biomet (ZBH) Revenue Jumps, Yet Stocks Slide

The diversified surgical equipment and consumables sector posted mixed first-quarter results, with group revenues surpassing analyst consensus by 1.1% but individual stocks reacting sharply in both directions. CONMED (NYSE:CNMD) delivered the biggest beat, while Zimmer Biomet (NYSE:ZBH) recorded the fastest revenue growth, yet both declined following their reports. CONMED’s revenue fell 1.3% year-on-year to $317 million, still beating estimates by 2.1%, but its shares dropped 3.9% to $34.57. Zimmer Biomet reported a 9.3% revenue jump to $2.09 billion, exceeding forecasts by 0.9%, yet its stock tumbled 10.6% to $82.77. STERIS (NYSE:STE) posted a 7.3% revenue increase to $1.59 billion, in line with expectations, and shares rose 4.6% to $211.06. Solventum (NYSE:SOLV) saw revenue decline 3% to $2.01 billion, the slowest in the group, but its stock surged 9.9% to $75.86. Becton Dickinson (NYSE:BDX) grew revenue 5.2% to $4.71 billion, a narrow beat, and shares inched up 1.1% to $146.34. The industry faces tailwinds from aging populations and AI-driven surgical innovation, but pricing pressures and cost-conscious healthcare customers remain persistent headwinds.